About Us
Who we are
Osteopore is a global medical technology company founded in Singapore and listed in Australia, commercialising products designed to enable natural bone healing across multiple therapeutic areas. Osteopore's patented technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material.
Osteopore's patent-protected scaffolds are manufactured using a proprietary manufacturing technique with a polymer that naturally dissolves over time to allow natural and healthy bone tissue, significantly reducing the post-surgery complications commonly associated with permanent bone implants. Our 3D printing technology is unique to Osteopore.
Our roots
Our founders, comprising a team of 6 clinicians and scientists, got together in 1996 to reimagine patient healing. They envisioned a future where bone and other tissues are empowered to heal with a technology that supports regeneration. In 2003, Osteopore was established.
Today, Osteopore continues to carry forth their vision for improved patient healing: expanding our global presence, developing cutting-edge technology, identifying new innovations.
Our technology
We are the first company in the world to obtain market authorisation for our 3D printed bone scaffold. Our core technology leverages our collective knowledge and experience on how bone and tissue heals – we continue to learn and adapt with every implant.
We believe in creating a conducive environment for tissue regrowth while minimising long-term impact of biomaterials that remain in the body. We own our technology – Osteopore’s 3D printers are designed to support our mission to Empower Natural Tissue Regeneration.
We continue to innovate by adopting an open innovation mindset – collaborations and joint-developments are part of our DNA.
